<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">352103</id>
  <title nil="true"/>
  <common-name>2-(4-fluorophenyl)-1-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-4-ium-1-yl]hexyl]imidazo[1,2-a]pyridin-4-ium</common-name>
  <description>2-(4-fluorophenyl)-1-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-4-ium-1-yl]hexyl]imidazo[1,2-a]pyridin-4-ium is a chemical compound with the formula C32H30F2N4+2. With an average molecular weight of 508.60 g/mol, 2-(4-fluorophenyl)-1-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-4-ium-1-yl]hexyl]imidazo[1,2-a]pyridin-4-ium is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>15588584</pubchem-id>
  <chemical-formula>C32H30F2N4+2</chemical-formula>
  <weight>508.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T18:15:03Z</created-at>
  <updated-at type="dateTime">2026-08-31T18:15:03Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=[N+]2C=C(N(C2=C1)CCCCCCN3C4=CC=CC=[N+]4C=C3C5=CC=C(C=C5)F)C6=CC=C(C=C6)F</moldb-smiles>
  <moldb-formula>C32H30F2N4+2</moldb-formula>
  <moldb-inchi>InChI=1S/C32H30F2N4/c33-27-15-11-25(12-16-27)29-23-35-19-7-3-9-31(35)37(29)21-5-1-2-6-22-38-30(26-13-17-28(34)18-14-26)24-36-20-8-4-10-32(36)38/h3-4,7-20,23-24H,1-2,5-6,21-22H2/q+2</moldb-inchi>
  <moldb-inchikey>ICPUYKZJGQVZHP-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">508.2438533</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>8.4</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM347996</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-(4-fluorophenyl)-1-[6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-4-ium-1-yl]hexyl]imidazo[1,2-a]pyridin-4-ium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Imidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0302393</sync-id>
  <structure-inchikey>ICPUYKZJGQVZHP-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>802000000000000000800000000000000000000000800000000000000000000000020000000000000000200000000001000000000000000000000000000000000000000000000000020080000010000000000000000000000000200000000000000000000004900000008100000000000000001000000000000000000000800000000000014000800000000100000000000200000000000000000000000000000000080000002000000002000000000000000000000000008000000000000000080000000000020000480000000000000200000000000000000000000000000040000000010000800000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKwAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:49:54Z</structure-indexed-at>
</compound>
